Koskinen L L E, Einarsdottir E, Korponay-Szabo I R, Kurppa K, Kaukinen K, Sistonen P, Pocsai Z, Széles G, Adány R, Mäki M, Kere J, Saavalainen P
Department of Medical Genetics and Research Program for Molecular Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.
Tissue Antigens. 2009 Nov;74(5):408-16. doi: 10.1111/j.1399-0039.2009.01359.x.
Celiac disease is a chronic inflammation of the small intestine, arising in genetically predisposed individuals as a result of ingestion of dietary gluten. The only confirmed and functionally characterised genetic risk factors for celiac disease are the DQ2 or DQ8 heterodimers at the major histocompatibility complex (MHC) class II locus (CELIAC1). These genes are necessary but alone not sufficient for disease onset. Genome-wide linkage scans have suggested chromosome 5q31-q33 (CELIAC2) as an important risk locus for celiac disease. This region has also been associated to other inflammatory disorders, although as yet, no clear gene associations have been found. In the current study, 11 celiac disease candidate loci were screened for genetic linkage in the Hungarian population. As the CELIAC2 locus showed the strongest evidence for linkage, this locus was selected for follow-up. Seventeen candidate genes were selected from the CELIAC2 locus, and genotyped using 48 haplotype tagging single nucleotide polymorphisms (SNPs) in large Finnish and Hungarian family materials. A subset of these, 40 tagging SNPs in 15 genes, were genotyped in an independent set of Finnish and Hungarian cases and controls. We confirmed linkage of this region with celiac disease and report strong linkage in both the Finnish and Hungarian populations. The association analysis showed modest associations throughout the whole region. These association findings were not replicated in the case-control datasets. Our study strongly supports the role of the CELIAC2 locus in celiac disease, but it also highlights the need for a more powerful study design in the region, to locate the true disease risk variants.
乳糜泻是一种小肠慢性炎症,发生于具有遗传易感性的个体,由摄入膳食中的麸质引发。乳糜泻唯一得到确认且具有功能特征的遗传风险因素是主要组织相容性复合体(MHC)II类基因座(CELIAC1)上的DQ2或DQ8异二聚体。这些基因是发病所必需的,但仅靠它们并不足以引发疾病。全基因组连锁扫描表明,5号染色体q31 - q33区域(CELIAC2)是乳糜泻的一个重要风险基因座。该区域也与其他炎症性疾病有关,不过目前尚未发现明确的基因关联。在本研究中,对匈牙利人群的11个乳糜泻候选基因座进行了遗传连锁筛查。由于CELIAC2基因座显示出最强的连锁证据,因此选择该基因座进行后续研究。从CELIAC2基因座中挑选了17个候选基因,并在芬兰和匈牙利的大型家系材料中使用48个单倍型标签单核苷酸多态性(SNP)进行基因分型。其中一部分,即15个基因中的40个标签SNP,在另一组独立的芬兰和匈牙利病例及对照中进行了基因分型。我们证实了该区域与乳糜泻的连锁关系,并报告在芬兰和匈牙利人群中均存在强连锁。关联分析显示在整个区域都存在适度关联。这些关联结果在病例对照数据集中未得到重复验证。我们的研究有力地支持了CELIAC2基因座在乳糜泻中的作用,但也凸显了在该区域需要更强大的研究设计来定位真正的疾病风险变异体。